Senseonics Holdings, Inc. - Common Stock (SENS)

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) reported record third-quarter revenue and raised its 2026 sales outlook for the third time this year, as new patient starts for its Eversense 365 continuous glucose monitor drove growth in the United States and abroad. Revenue rose approximately

Cramer recommends buying Carpenter Technology (NYSE: CRS) and calls DXC Technology (NYSE: DXC) a value trap. Senseonics Holdings (NASDAQ: SENS) posts upbeat sales and Ubiquiti (NYSE: UI) reports worse-than-expected results. Hess Midstream (NYSE: HESM) is a winner while Zeta Global (NYSE: ZETA) announces a new CMO. UL Solutions (NYSE: ULS) is a potential buy and Coupang (NYSE: CPNG) is not recommended, but MercadoLibre (NASDAQ: MELI) and Amazon (NASDAQ: AMZN) are worth considering.

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) raised its full-year 2026 revenue and gross-margin outlook after reporting second-quarter revenue growth of approximately 120% and its highest organic gross margin to date. Net revenue for the second quarter totaled $14.5 million, compared with $